Literature DB >> 2394349

Predictability of the postoperative course of Crohn's disease.

P Rutgeerts1, K Geboes, G Vantrappen, J Beyls, R Kerremans, M Hiele.   

Abstract

Eighty-nine patients who had been treated by ileal resection for Crohn's disease between 1979 and 1984 were included in a prospective cohort follow up to study the natural course of early postoperative lesions. Recurrent lesions were observed endoscopically in the neoterminal ileum within 1 year of surgery in 73% of the patients, although only 20% of the patients had symptoms. Three years after surgery, the endoscopic recurrence rate had increased to 85% and symptomatic recurrence occurred in 34%. The ultimate course of the disease was best predicted by the severity of the early postoperative lesions, as observed at ileoscopy. Clinical parameters that influenced outcome were preoperative disease activity, the indication for surgery, and the number of surgical resections. When patients were stratified for preoperative disease activity, the severity of lesions found at endoscopy remained a strong predictive factor for symptomatic recurrence. In 22 other patients submitted to "curative" ileal resection and ileocolonic anastomosis, the segment to be used as neoterminal ileum was carefully examined during surgery, and two large biopsies were taken before making the anastomosis. An ileoscopy was performed 6 months after surgery. Although all patients had a macroscopically normal neoterminal ileum and 19 had entirely normal biopsies at the time of surgery, 21 patients were found at ileoscopy to have developed ileitis involving a 15-cm segment (range, 4-30 cm), and 20 had unequivocal microscopic lesions on biopsies. These studies suggest that early lesions in the neoterminal ileum after Crohn's resection do not originate from microscopic inflammation present in this bowel segment at the time of surgery. The early postoperative lesions in the neoterminal ileum seem to be a suitable model to study the pathogenesis of Crohn's disease and also to evaluate new therapeutic modalities, either to prevent development of these early lesions or to treat progressive recurrence.

Entities:  

Mesh:

Year:  1990        PMID: 2394349     DOI: 10.1016/0016-5085(90)90613-6

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  393 in total

Review 1.  [Clinical effects of 5-aminosalicylic acid preparations in Crohn disease].

Authors:  W E Fleig
Journal:  Med Klin (Munich)       Date:  1999-02-15

2.  Enhanced production of IL-8 in chronic but not in early ileal lesions of Crohn's disease (CD).

Authors:  E Brandt; J F Colombel; N Ectors; L Gambiez; D Emilie; K Geboes; M Capron; P Desreumaux
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

Review 3.  Medical management of postoperative complications of inflammatory bowel disease: pouchitis and Crohn's disease recurrence.

Authors:  J P Achkar; B Shen
Journal:  Curr Gastroenterol Rep       Date:  2001-12

4.  Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics.

Authors:  E A Vasiliauskas; L Y Kam; L C Karp; J Gaiennie; H Yang; S R Targan
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

Review 5.  Prevention of postoperative recurrence in Crohn's disease.

Authors:  G D'Haens
Journal:  Curr Gastroenterol Rep       Date:  1999-12

6.  Serial intralesional injections of infliximab in small bowel Crohn's strictures are feasible and might lower inflammation.

Authors:  Jakob Hendel; John Gásdal Karstensen; Peter Vilmann
Journal:  United European Gastroenterol J       Date:  2014-10       Impact factor: 4.623

Review 7.  An evolutionary perspective on field cancerization.

Authors:  Kit Curtius; Nicholas A Wright; Trevor A Graham
Journal:  Nat Rev Cancer       Date:  2017-12-08       Impact factor: 60.716

8.  Intravenous Contrast-Enhanced Ultrasound for Assessing and Grading Postoperative Recurrence of Crohn's Disease.

Authors:  María Jesús Martínez; Tomás Ripollés; Jose María Paredes; Eduardo Moreno-Osset; Juan Manuel Pazos; Esther Blanc
Journal:  Dig Dis Sci       Date:  2019-01-02       Impact factor: 3.199

9.  Meta-analysis of medical treatment and placebo treatment for preventing postoperative recurrence in Crohn's disease (CD).

Authors:  Yunfei Cao; Feng Gao; Cun Liao; Aihua Tan; Zengnan Mo
Journal:  Int J Colorectal Dis       Date:  2009-01-27       Impact factor: 2.571

Review 10.  A Comprehensive Review of the Diagnosis and Pharmacological Management of Crohn's Disease in the Elderly Population.

Authors:  David Kim; Sasha Taleban
Journal:  Drugs Aging       Date:  2019-07       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.